TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive The St. Louis Meetings; Ultman Raps NCA “Politization”, Calls for Improvement In Communications; Weinhouse Says Researcher “Caught In Crossfire”; ONS Success Vaults Nurses Into Strong Position Nationally May 7, 1982
TCL Archive Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage March 21, 2014
